Cargando…

260. Durability of Antibody Responses to RSV in Older Adults Following Hospitalization for Acute Respiratory Infection

BACKGROUND: Respiratory syncytial virus (RSV) is a common viral pathogen identified in older adults with acute respiratory infections (ARIs). Data describing the durability of immune responses to RSV are limited but suggest responses may be short-lived. In this study, we assessed longitudinal antibo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciric, Caroline, Ha, Binh, Tippett, Ashley, Hussaini, Laila, Salazar, Luis W, Reese, Olivia, Li, Wensheng, Hsiao, Hui-Mien, Gibson, Theda, Begier, Elizabeth, Hubler, Robin, Liu, Qing, Gessner, Bradford J, Lopman, Benjamin, Rouphael, Nadine, Kamidani, Satoshi, Anderson, Evan J, Anderson, Larry, Rostad, Christina A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678493/ http://dx.doi.org/10.1093/ofid/ofad500.332

Ejemplares similares

2621. Social Risk Factors for RSV-related Hospitalizations in Adults ≥ 50 years of age
por: De Castro, Khalel, et al.
Publicado: (2023)

892. Epidemiology, clinical features, and outcomes of Rhinovirus/Enterovirus in older adults hospitalized with acute respiratory infections and those with CHF and COPD exacerbations
por: Ess, Gabby, et al.
Publicado: (2023)

1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Salazar, Luis W, et al.
Publicado: (2021)

1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Taylor, Megan, et al.
Publicado: (2021)

1340. The Burden of Influenza and Rhinovirus Among Hospitalized Adults Post the COVID-19 Pandemic
por: Reese, Olivia D, et al.
Publicado: (2021)

430. Clinical Features and Outcomes of COVID-19 Hospitalized Adults by Variant
por: Perez, Maria A, et al.
Publicado: (2023)

1068. Prior SARS-CoV-2 infection and risk of subsequent COVID-19-related hospitalization: a test negative design
por: Castro, Khalel De, et al.
Publicado: (2022)

1908. Social Risk Factors for COVID-19-Related Hospitalizations in Adults
por: Reese, Olivia D, et al.
Publicado: (2022)

1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination
por: Choi, Chris, et al.
Publicado: (2022)

Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera
por: Ha, Binh, et al.
Publicado: (2021)

447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection
por: Taylor, Elizabeth G, et al.
Publicado: (2023)

2364. Predictive Ability of mRNA COVID-19 Vaccines Against COVID-19 Disease Severity
por: Lew, Ashley, et al.
Publicado: (2023)

The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein
por: Chen, Xuemin, et al.
Publicado: (2021)

2314. Burden of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Anderson, Evan J, et al.
Publicado: (2019)

Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination
por: Chen, Xuemin, et al.
Publicado: (2023)

1019. Respiratory Syncytial Virus (RSV) Diagnoses in Hospitalized Patients Increases when Additional Specimen Types are Added to Nasopharyngeal Swab: Results from the RSV in Adults Multispecimen Study
por: Ramirez, Julio, et al.
Publicado: (2023)

Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study
por: Li, You, et al.
Publicado: (2023)

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
por: Roe, Molly K, et al.
Publicado: (2022)

Addressing the global burden of paediatric critical COVID-19 and mortality
por: Kamidani, Satoshi, et al.
Publicado: (2022)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

2629. Estimation of Hospitalization and Mortality Burden of RSV in Adults in Spain between 2015–2019
por: Haeberer, Mariana, et al.
Publicado: (2023)

In vitro model for the assessment of human immune responses to subunit RSV vaccines
por: Chirkova, Tatiana, et al.
Publicado: (2020)

Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
por: Jadhao, Samadhan J., et al.
Publicado: (2016)

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
por: Wilkins, Deidre, et al.
Publicado: (2023)

SARS-CoV-2 Antibody Profiles in Maternal Serum and Breast Milk Following mRNA COVID-19 Vaccination: A Longitudinal Prospective Observational Cohort Study
por: Hsiao, Hui-Mien, et al.
Publicado: (2023)

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
por: Boyoglu-Barnum, Seyhan, et al.
Publicado: (2019)

260 modelos de ventanas
por: Ayuso, Carlos
Publicado: (1991)

Status Report on P260
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1992)

888. Estimation of the Incidence of RSV-attributable Circulatory and Respiratory Hospital Admissions in Adults in Germany between 2015–2019, Overall and for Specific Conditions
por: Beese, Caroline, et al.
Publicado: (2023)

Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
por: Lapp, Stacey A., et al.
Publicado: (2021)

260. Effect of Antibiotic Indications on Clinician Documentation and Pharmacy Workflow in Hospitalized Children
por: Scardina, Tonya, et al.
Publicado: (2018)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

Health Tract, No. 260: Sun-Stroke
Publicado: (1866)

Health Tract, No. 260: Immortality’s Dawn
Publicado: (1866)

Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
por: Mantus, Grace, et al.
Publicado: (2022)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19
por: Ngo, Binh, et al.
Publicado: (2021)

Résumé de mathématique avec 260 problèmes
por: Roth, Charles
Publicado: (1967)

Release Note -- Vbfnlo-2.6.0
por: Arnold, K., et al.
Publicado: (2012)

A260 ACUTE PANCREATITIS IN JORDANIAN CHILDREN
por: Altamimi, E M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9auma5mn06trpkoh1bnt0hc12o